Cargando…
Diabetic Proteinuria Revisited: Updated Physiologic Perspectives
Albuminuria, a hallmark of diabetic nephropathy, reflects not only injury and dysfunction of the filtration apparatus, but is also affected by altered glomerular hemodynamics and hyperfiltration, as well as by the inability of renal tubular cells to fully retrieve filtered albumin. Albuminuria furth...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496872/ https://www.ncbi.nlm.nih.gov/pubmed/36139492 http://dx.doi.org/10.3390/cells11182917 |
_version_ | 1784794377191686144 |
---|---|
author | Heyman, Samuel N. Raz, Itamar Dwyer, Jamie P. Weinberg Sibony, Roni Lewis, Julia B. Abassi, Zaid |
author_facet | Heyman, Samuel N. Raz, Itamar Dwyer, Jamie P. Weinberg Sibony, Roni Lewis, Julia B. Abassi, Zaid |
author_sort | Heyman, Samuel N. |
collection | PubMed |
description | Albuminuria, a hallmark of diabetic nephropathy, reflects not only injury and dysfunction of the filtration apparatus, but is also affected by altered glomerular hemodynamics and hyperfiltration, as well as by the inability of renal tubular cells to fully retrieve filtered albumin. Albuminuria further plays a role in the progression of diabetic nephropathy, and the suppression of glomerular albumin leak is a key factor in its prevention. Although microalbuminuria is a classic manifestation of diabetic nephropathy, often progressing to macroalbuminuria or overt proteinuria over time, it does not always precede renal function loss in diabetes. The various components leading to diabetic albuminuria and their associations are herein reviewed, and the physiologic rationale and efficacy of therapeutic interventions that reduce glomerular hyperfiltration and proteinuria are discussed. With these perspectives, we propose that these measures should be initiated early, before microalbuminuria develops, as substantial renal injury may already be present in the absence of proteinuria. We further advocate that the inhibition of the renin–angiotensin axis or of sodium–glucose co-transport likely permits the administration of a normal recommended or even high-protein diet, highly desirable for sarcopenic diabetic patients. |
format | Online Article Text |
id | pubmed-9496872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94968722022-09-23 Diabetic Proteinuria Revisited: Updated Physiologic Perspectives Heyman, Samuel N. Raz, Itamar Dwyer, Jamie P. Weinberg Sibony, Roni Lewis, Julia B. Abassi, Zaid Cells Review Albuminuria, a hallmark of diabetic nephropathy, reflects not only injury and dysfunction of the filtration apparatus, but is also affected by altered glomerular hemodynamics and hyperfiltration, as well as by the inability of renal tubular cells to fully retrieve filtered albumin. Albuminuria further plays a role in the progression of diabetic nephropathy, and the suppression of glomerular albumin leak is a key factor in its prevention. Although microalbuminuria is a classic manifestation of diabetic nephropathy, often progressing to macroalbuminuria or overt proteinuria over time, it does not always precede renal function loss in diabetes. The various components leading to diabetic albuminuria and their associations are herein reviewed, and the physiologic rationale and efficacy of therapeutic interventions that reduce glomerular hyperfiltration and proteinuria are discussed. With these perspectives, we propose that these measures should be initiated early, before microalbuminuria develops, as substantial renal injury may already be present in the absence of proteinuria. We further advocate that the inhibition of the renin–angiotensin axis or of sodium–glucose co-transport likely permits the administration of a normal recommended or even high-protein diet, highly desirable for sarcopenic diabetic patients. MDPI 2022-09-18 /pmc/articles/PMC9496872/ /pubmed/36139492 http://dx.doi.org/10.3390/cells11182917 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Heyman, Samuel N. Raz, Itamar Dwyer, Jamie P. Weinberg Sibony, Roni Lewis, Julia B. Abassi, Zaid Diabetic Proteinuria Revisited: Updated Physiologic Perspectives |
title | Diabetic Proteinuria Revisited: Updated Physiologic Perspectives |
title_full | Diabetic Proteinuria Revisited: Updated Physiologic Perspectives |
title_fullStr | Diabetic Proteinuria Revisited: Updated Physiologic Perspectives |
title_full_unstemmed | Diabetic Proteinuria Revisited: Updated Physiologic Perspectives |
title_short | Diabetic Proteinuria Revisited: Updated Physiologic Perspectives |
title_sort | diabetic proteinuria revisited: updated physiologic perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496872/ https://www.ncbi.nlm.nih.gov/pubmed/36139492 http://dx.doi.org/10.3390/cells11182917 |
work_keys_str_mv | AT heymansamueln diabeticproteinuriarevisitedupdatedphysiologicperspectives AT razitamar diabeticproteinuriarevisitedupdatedphysiologicperspectives AT dwyerjamiep diabeticproteinuriarevisitedupdatedphysiologicperspectives AT weinbergsibonyroni diabeticproteinuriarevisitedupdatedphysiologicperspectives AT lewisjuliab diabeticproteinuriarevisitedupdatedphysiologicperspectives AT abassizaid diabeticproteinuriarevisitedupdatedphysiologicperspectives |